These observations suggest that the improved antitumor immunity in Cd4-Cre+Lsd1f/f mice is likely due to a role of LSD1 in regulating the activation and differentiation of mature T cells upon tumor antigen stimulation, which is further supported by our chemical approach with the LSD1 inhibitors. The gene discussed is KDM1A; the disease is neoplasm.